Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
national blog main
new york blog main
6
×
life sciences
boston blog main
boston top stories
national top stories
new york top stories
san francisco blog main
startups
boston
cancer
clinical trials
detroit blog main
detroit top stories
merck
raleigh-durham blog main
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco top stories
wisconsin blog main
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alirocumab
alnylam pharmaceuticals
alzheimer's
ameet nathwani
amgen
aphelion capital
arboretum ventures
arches
aurora health care
azacitidine
baird capital
beta-thalassemia
biolinq
boulder/denver blog main
What
based
6
×
new
medicines
million
startup
research
step
adds
advance
aims
alnylam
american
ann
approach
arbor
begin
best
bio
biolinq
biosciences
biosensor
biotech
bio’s
brings
bubbles
called
cells
cholesterol
class
clinical
closed
codiak
company
continue
crash
data
debate
debuts
developing
diabetes
Language
unset
Current search:
based
×
biotech
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round